Veracyte Inc (VCYT)
20.35
+0.16
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
20.35
0.00 (0.00%)
After-Hours: 20:00
Veracyte Price to Book Value: 1.463 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.463 |
| May 02, 2024 | 1.452 |
| May 01, 2024 | 1.447 |
| April 30, 2024 | 1.407 |
| April 29, 2024 | 1.462 |
| April 26, 2024 | 1.388 |
| April 25, 2024 | 1.401 |
| April 24, 2024 | 1.431 |
| April 23, 2024 | 1.426 |
| April 22, 2024 | 1.427 |
| April 19, 2024 | 1.398 |
| April 18, 2024 | 1.380 |
| April 17, 2024 | 1.356 |
| April 16, 2024 | 1.360 |
| April 15, 2024 | 1.393 |
| April 12, 2024 | 1.454 |
| April 11, 2024 | 1.490 |
| April 10, 2024 | 1.489 |
| April 09, 2024 | 1.541 |
| April 08, 2024 | 1.488 |
| April 05, 2024 | 1.447 |
| April 04, 2024 | 1.450 |
| April 03, 2024 | 1.483 |
| April 02, 2024 | 1.475 |
| April 01, 2024 | 1.556 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.593 |
| March 27, 2024 | 1.562 |
| March 26, 2024 | 1.521 |
| March 25, 2024 | 1.510 |
| March 22, 2024 | 1.516 |
| March 21, 2024 | 1.551 |
| March 20, 2024 | 1.554 |
| March 19, 2024 | 1.558 |
| March 18, 2024 | 1.552 |
| March 15, 2024 | 1.517 |
| March 14, 2024 | 1.528 |
| March 13, 2024 | 1.587 |
| March 12, 2024 | 1.605 |
| March 11, 2024 | 1.629 |
| March 08, 2024 | 1.634 |
| March 07, 2024 | 1.636 |
| March 06, 2024 | 1.606 |
| March 05, 2024 | 1.65 |
| March 04, 2024 | 1.692 |
| March 01, 2024 | 1.726 |
| February 29, 2024 | 1.693 |
| February 28, 2024 | 1.709 |
| February 27, 2024 | 1.698 |
| February 26, 2024 | 1.694 |
| February 23, 2024 | 1.595 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.017
Minimum
May 11 2022
16.35
Maximum
Jun 17 2019
3.881
Average
2.636
Median
Jun 17 2021
Price to Book Value Benchmarks
| Fonar Corp | 0.6425 |
| XWELL Inc | 0.5759 |
| ProPhase Labs Inc | 2.094 |
| Applied DNA Sciences Inc | 0.7647 |
| OncoCyte Corp | 1.733 |
Price to Book Value Related Metrics
| PS Ratio | 4.094 |
| PEG Ratio | -0.1864 |
| Price to Free Cash Flow | 43.15 |
| Price | 20.35 |
| Earnings Yield | -5.06% |
| Market Cap | 1.528B |
| PEGY Ratio | -0.1864 |